I see no reason for the share price to go up so sharply over the last few trading sessions.
Trading updates don't excite the market anymore.
The short sales have been steadily increasing for weeks.
Now at 41.5 million shares.
I think Z1P could go down to under $5 by next week if they release the trading update over the next few trading sessions.
- Forums
- ASX - By Stock
- Big short squeeze
I see no reason for the share price to go up so sharply over the...
-
- There are more pages in this discussion • 898 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZIP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.00 |
Change
0.110(3.81%) |
Mkt cap ! $3.916B |
Open | High | Low | Value | Volume |
$2.92 | $3.00 | $2.92 | $36.33M | 12.20M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 14534 | $2.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.00 | 728349 | 93 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 14534 | 2.990 |
9 | 137340 | 2.980 |
12 | 130929 | 2.970 |
5 | 272596 | 2.960 |
8 | 170828 | 2.950 |
Price($) | Vol. | No. |
---|---|---|
3.000 | 702420 | 87 |
3.010 | 275546 | 11 |
3.020 | 374728 | 16 |
3.030 | 301340 | 16 |
3.040 | 190031 | 9 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
ZIP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online